Average Co-Inventor Count = 6.29
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cancer Research Technology Limited (6 from 262 patents)
2. The Institute of Cancer Research: Royal Cancer Hospital (1 from 51 patents)
7 patents:
1. 11814370 - Deuterated N-(5-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)-2-fluorophenyl)-2-((4-ethylpiperazin-1-yl)methyl)quinoline-6-carboxamide
2. 11787786 - Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
3. 11124501 - Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
4. 10647678 - Quinoline derivatives as inhibitors of heat shock factor 1 pathway activity
5. 10189821 - Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
6. 9701664 - Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
7. 9550764 - Fused heterocyclic compounds and their use